SCHEMBL4622385

SCHEMBL4622385

Cc1c(F)ccc(C(=O)Cl)c1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
ALOX15 P16050 1/20 0.47
CES2 O00748 7/20 0.43
CES1 P23141 7/20 0.43
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
BCHE P06276 1/20 0.33
ADRA2A P08913 1/20 0.33
CLCN2 P51788 1/20 0.33
HPGD P15428 1/20 0.33
DAO P14920 1/20 0.33
HDAC4 P56524 1/20 0.32
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
EPRS1 P07814 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6364782 0.83 CES2 (0.48) ALDH1A1ALOX15CES2CES1BCHE
SCHEMBL9712390 0.82 HPGD (0.42) ALDH1A1ALOX15CES2CES1ADRA2A
SCHEMBL106326 0.82 ALDH1A1 (0.45) ALDH1A1ALOX15CES2CES1ADRA2A
SCHEMBL1192063 0.81 CES2 (0.45) ALDH1A1ALOX15CES2CES1ADRA2A
SCHEMBL4621035 0.81 CES2 (0.45) CES2CES1ESR1ESR2BCHE
SCHEMBL525011 0.80 CES2 (0.67) ALDH1A1ALOX15CES2CES1BCHE
SCHEMBL3453035 0.80 ALDH1A1 (0.44) ALDH1A1ALOX15CES2CES1ESR1
SCHEMBL109636 0.78 ALDH1A1 (0.45) ALDH1A1ALOX15CES2CES1ADRA2A
Benzoyl Chloride SCHEMBL8166169 0.78 ALDH1A1 (0.36) ALDH1A1ALOX15NPC1HTTRAB9A
SCHEMBL1020497 0.77 ALDH1A1 (0.43) ALDH1A1ALOX15CES2CES1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1514864-B1 Difluoralkyl aromatic compounds SALTIGO GMBH (DE) 2008-03-19 EP claimed
US-20050054733-A1 Difluoroalkylaromatics LANXESS DEUTSCHLAND GMBH (DE) 2005-03-10 US claimed
CN-117720495-A Preparation method of novel amide-containing coumarin derivative, antibacterial effect of composition and application of composition in aspect of promoting plant growth 贵州工业职业技术学院 2024-03-19 CN disclosed
CN-105175284-B Amides compound, preparation method and its medical usage 中国药科大学 2017-06-16 CN disclosed
CN-105175284-A Amide compounds, preparation method and medical use thereof UNIV CHINA PHARMA 2015-12-23 CN disclosed
EP-1514864-A2 Difluoralkyl aromatic compounds Bayer Chemicals AG (DE) 2005-03-16 EP disclosed
US-20050054733-A1 Difluoroalkylaromatics LANXESS DEUTSCHLAND GMBH (DE) 2005-03-10 US disclosed
US-5648567-A INTERMEDIATES FOR BACTERICIDES BAYER AKTIENGESELLSCHAFT (DE) 1997-07-15 US disclosed
US-5493048-A REACTING METALLIZED FLUORO-TRIFLUOROMETHYLBENZENE DERIVATIVE WITH CARBON DIOXIDE AND PRODUCT IS THEN HYDROLYSED WITH AN ACID TO FORM ACID, SIMILARLY HALOGENATION GIVE ACID HALIDE AND WITH ALCOHOL GIVES ESTER BAYER AKTIENGESELLSCHAFT (DE) 1996-02-20 US disclosed
US-5117057-A Insecticidal N' substituted-N-N'-disubstituted-hydrazines ROHM AND HAAS COMPANY (US) 1992-05-26 US disclosed
US-4870182-A 4-Hydroxy-quinoline-3-carboxylic BAYER AKTIENGESELLSCHAFT (DE) 1989-09-26 US disclosed
US-4804760-A Process for the preparation of 4-hydroxy-quinoline-3-carboxylic acids BAYER AKTIENGESELLSCHAFT (DE) 1989-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054733-A1 Difluoroalkylaromatics NQO1, TYR, FLI1 ALDH1A1 393/4885ALOX15 2466/4885CES2 141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.